DK166732B1 - Monoklonalt antistof, hybridomacellelinie, som kan producere det samt dets anvendelse ved immunologiske fremgangsmaader til isolering eller kvantitativ paavisning af glycoprotein d i herpes simplex virus type 1 eller type 2 og i et immunoabsorptionsmateriale til brug ved affinitetsrensning af glycoprotein d. - Google Patents

Monoklonalt antistof, hybridomacellelinie, som kan producere det samt dets anvendelse ved immunologiske fremgangsmaader til isolering eller kvantitativ paavisning af glycoprotein d i herpes simplex virus type 1 eller type 2 og i et immunoabsorptionsmateriale til brug ved affinitetsrensning af glycoprotein d. Download PDF

Info

Publication number
DK166732B1
DK166732B1 DK187286A DK187286A DK166732B1 DK 166732 B1 DK166732 B1 DK 166732B1 DK 187286 A DK187286 A DK 187286A DK 187286 A DK187286 A DK 187286A DK 166732 B1 DK166732 B1 DK 166732B1
Authority
DK
Denmark
Prior art keywords
monoclonal antibody
glycoprotein
hybridoma cell
cell line
type
Prior art date
Application number
DK187286A
Other languages
Danish (da)
English (en)
Other versions
DK187286A (da
DK187286D0 (da
Inventor
Gary H Cohen
Roselyn J Eisenberg
Original Assignee
University Patents Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Patents Inc filed Critical University Patents Inc
Publication of DK187286A publication Critical patent/DK187286A/da
Publication of DK187286D0 publication Critical patent/DK187286D0/da
Application granted granted Critical
Publication of DK166732B1 publication Critical patent/DK166732B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/085—Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
    • C07K16/087—Herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/811—Peptides or proteins is immobilized on, or in, an inorganic carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/224—Herpes related

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK187286A 1984-08-24 1986-04-23 Monoklonalt antistof, hybridomacellelinie, som kan producere det samt dets anvendelse ved immunologiske fremgangsmaader til isolering eller kvantitativ paavisning af glycoprotein d i herpes simplex virus type 1 eller type 2 og i et immunoabsorptionsmateriale til brug ved affinitetsrensning af glycoprotein d. DK166732B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US64420584A 1984-08-24 1984-08-24
US64420584 1984-08-24
US69658285 1985-01-31
US06/696,582 US4745182A (en) 1984-08-24 1985-01-31 Herpes virus specific immunological materials and methods
US8501481 1985-08-05
PCT/US1985/001481 WO1986001517A1 (en) 1984-08-24 1985-08-05 Herpes virus specific immunological materials and methods

Publications (3)

Publication Number Publication Date
DK187286A DK187286A (da) 1986-04-23
DK187286D0 DK187286D0 (da) 1986-04-23
DK166732B1 true DK166732B1 (da) 1993-07-05

Family

ID=27094428

Family Applications (1)

Application Number Title Priority Date Filing Date
DK187286A DK166732B1 (da) 1984-08-24 1986-04-23 Monoklonalt antistof, hybridomacellelinie, som kan producere det samt dets anvendelse ved immunologiske fremgangsmaader til isolering eller kvantitativ paavisning af glycoprotein d i herpes simplex virus type 1 eller type 2 og i et immunoabsorptionsmateriale til brug ved affinitetsrensning af glycoprotein d.

Country Status (20)

Country Link
US (1) US4745182A (de)
EP (1) EP0172471B1 (de)
JP (2) JP2559366B2 (de)
KR (1) KR910002552B1 (de)
AT (1) ATE72267T1 (de)
AU (1) AU592064B2 (de)
CA (1) CA1254161A (de)
DE (1) DE3585306D1 (de)
DK (1) DK166732B1 (de)
ES (1) ES8607562A1 (de)
FI (1) FI102838B (de)
GR (1) GR852018B (de)
HU (1) HU195247B (de)
IE (1) IE59461B1 (de)
IL (1) IL76013A (de)
NO (1) NO170025C (de)
NZ (1) NZ213016A (de)
PH (1) PH21407A (de)
PL (1) PL150778B1 (de)
WO (1) WO1986001517A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149660A (en) * 1982-02-18 1992-09-22 University Patents, Inc. Diagnostic reagents relating to herpes simplex virus
DE3510734A1 (de) * 1985-03-25 1986-09-25 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines fuer herpes simplex virus typ 2 spezifischen antigens, dazu geeignetes mittel und verwendung dieses antigens
US5250410A (en) * 1987-01-27 1993-10-05 Allegheny-Singer Research Institute Rapid detection of herpes virus with lectin
US5646041A (en) * 1987-02-12 1997-07-08 Harfeldt; Elisabeth Monoclonal antibody to herpes simplex virus and cell line producing same
WO1990001324A1 (en) * 1988-08-10 1990-02-22 Stephen Leslie Sacks PRODUCTION OF RADIOIODINATED 1-β-D-ARABINOFURANOSYL)-5(E)-(2-IODOVINYL)URACIL, AND USES THEREOF, AND RELATED ANALOGUES INCORPORATING ALTERNATIVE HALOGEN RADIONUCLIDES, THE GENERAL RADIOHALOGENATION PRECURSORS, 1-(2,3,5-TRI-O-ACETYL-β-D-ARABINOFURANOSYL)-5(Z and E)-(2-TRIMETHYLSILYLVINYL)URACIL, PROCESSES FOR RADIOHA
US5081010A (en) * 1989-02-09 1992-01-14 Eastman Kodak Company Extraction composition, test kit and their use to extract or determine herpes simplex viral antigen
WO1990013652A1 (en) * 1989-05-12 1990-11-15 Triton Diagnostics, Inc. Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
ATE155583T1 (de) * 1991-03-06 1997-08-15 Ortho Diagnostic Systems Inc Denaturierte transportproteine zur verbesserung von enzymgebundenen immunoassays (elisa)
US5654174A (en) * 1995-07-07 1997-08-05 Competitive Technologies, Inc. Herpes simplex virus glycoprotein D variants
US7267940B2 (en) * 2003-03-04 2007-09-11 Bio-Rad Laboratories, Inc. HSV-2 type-specific immunoassays using glycoprotein G2 peptides
US8252906B2 (en) 2009-01-05 2012-08-28 Dcb-Usa Llc Anti-herpes simplex virus antibodies and methods of use thereof
WO2010087813A1 (en) * 2009-01-05 2010-08-05 Dcb-Usa Llc Anti-herpes simplex virus antibodies
EP2308895A1 (de) 2009-10-01 2011-04-13 Universität Duisburg-Essen Anti-HSV-Antikörper
EP2694542A4 (de) * 2011-04-08 2014-10-08 Univ Duke Herpes-simplex-virus
WO2024117057A1 (ja) * 2022-11-28 2024-06-06 マルホ株式会社 抗体またはその抗原結合性断片、およびこれを用いた免疫学的測定装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4572896A (en) * 1980-08-27 1986-02-25 The United States Of America As Represented By The Department Of Health And Human Services Monoclonal antibodies to herpes simplex virus type I polypeptides
US4430437A (en) * 1980-08-27 1984-02-07 The United States Of America As Represented By The Department Of Health And Human Services Test methods employing monoclonal antibodies against Herpes simplex virus types 1 and 2 nucleocapsids proteins
CA1240937A (en) * 1982-07-26 1988-08-23 Gordon R. Dreesman Monoclonal igm antibodies and method of preparation
US4535057A (en) * 1982-07-26 1985-08-13 Amf Incorporated Immunoassay employing monoclonal herpes simplex antibody and biotin-avidin detection system
US4618570A (en) * 1984-03-27 1986-10-21 Konishiroku Photo Industry Co., Ltd. Silver halide photographic materials

Also Published As

Publication number Publication date
GR852018B (de) 1985-12-24
HU195247B (en) 1988-04-28
FI102838B1 (fi) 1999-02-26
IE59461B1 (en) 1994-02-23
PL255119A1 (en) 1987-07-27
HUT40693A (en) 1987-01-28
EP0172471A3 (en) 1988-05-18
PL150778B1 (en) 1990-06-30
JP2574992B2 (ja) 1997-01-22
ES546354A0 (es) 1986-06-16
JP2559366B2 (ja) 1996-12-04
DE3585306D1 (de) 1992-03-12
FI102838B (fi) 1999-02-26
NZ213016A (en) 1989-07-27
KR910002552B1 (ko) 1991-04-24
PH21407A (en) 1987-10-15
EP0172471B1 (de) 1992-01-29
JPH06225759A (ja) 1994-08-16
DK187286A (da) 1986-04-23
ES8607562A1 (es) 1986-06-16
EP0172471A2 (de) 1986-02-26
FI861708A7 (fi) 1986-04-23
IL76013A (en) 1990-04-29
IL76013A0 (en) 1985-12-31
NO170025C (no) 1992-09-02
AU592064B2 (en) 1990-01-04
AU4725885A (en) 1986-03-24
WO1986001517A1 (en) 1986-03-13
DK187286D0 (da) 1986-04-23
JPS62500032A (ja) 1987-01-08
KR860005829A (ko) 1986-08-13
US4745182A (en) 1988-05-17
ATE72267T1 (de) 1992-02-15
CA1254161A (en) 1989-05-16
IE852072L (en) 1986-02-24
NO861597L (no) 1986-04-23
NO170025B (no) 1992-05-25
FI861708A0 (fi) 1986-04-23

Similar Documents

Publication Publication Date Title
FI114802B (fi) Epstein-Barr-virukseen liittyviä peptidejä ja nukleiinihapposekvenssejä
Dillner et al. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.
CA2071908C (en) Antibody antagonists of human interleukin-4
JP2665332B2 (ja) ヘルペス・シンプレツクスウイルスのワクチン接種の材料および方法
US4476049A (en) Method for the extraction of immune interferon
US4604284A (en) Homogeneous immune interferon fragment
KR910002552B1 (ko) 헤르페스 비루스 특이성 면역학적 물질 및 방법
US4709011A (en) Materials and methods for herpes simplex virus vaccination
US5451658A (en) Antagonists of human gamma interferon
AU707301B2 (en) Epstein-Barr virus peptides and antibodies against these peptides
EP0767678A1 (de) Kompositionen zur transaktivierung von proteinen als humanen immunschwächevirus
US5003043A (en) Peptides representing epitopic sites for the major HTLV-I envelope protein, antibodies thereto, and uses thereof
US6365717B1 (en) Peptides and nucleic acid sequences related to the Epstein Barr virus
Stoltz et al. Structural and Immunogenic Properties of a Major Antigenic Determinant in Neutral Salt‐Extracted Rat‐Skin Collagen
JPH07501710A (ja) エプスタイン・バールウイルスのペプチド及びこれらのペプチドに対する抗体
Chang et al. Monoclonal antibody for the detection and identification of a phytoplasma associated with rice yellow dwarf
KR920001772B1 (ko) 포유류 중의 HIV-억제 항체 유도성 사람 면역 결핍 바이러스(HIV) env-암호화된 펩타이드
Luijten et al. Monoclonal antibodies to P2 basic protein and their use in the investigation of some aspects of the Guillain-Barré syndrome
Qureshi et al. Identification and production of monoclonal antibodies against a discriminating protein molecule between B and D variants of encephalomyocarditis virus

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK